论文部分内容阅读
目的观察痰热清联合阿奇霉素治疗小儿支原体肺炎的临床疗效。方法将本院收治的支原体肺炎患儿86例按随机数字表法分为对照组和观察组各43例,对照组给予阿奇霉素治疗,观察组在对照组基础上加用痰热清注射液治疗,比较两组治疗后疗效。结果两组总有效率分别为76.74%和95.35%,观察组疗效显著优于对照组,差异有统计学意义(P<0.05);观察组平均退热时间、咳嗽消失时间、肺部湿啰音消失时间及住院时间短于对照组,差异均有统计学意义(P<0.05)。结论痰热清联合阿奇霉素治疗小儿支原体肺炎可提高患儿的疗效,改善症状,缩短治疗时间,值得临床推广。
Objective To observe the clinical efficacy of Tanreqing combined with Azithromycin in the treatment of Mycoplasma pneumonia in children. Methods 86 cases of mycoplasma pneumonia admitted in our hospital were randomly divided into control group and observation group (n = 43). The control group was treated with azithromycin. The observation group was treated with Tanreqing Injection on the basis of the control group. The curative effect of the two groups was compared. Results The total effective rates of the two groups were 76.74% and 95.35%, respectively. The curative effect of the observation group was significantly better than that of the control group (P <0.05). The average antipyretic time, cough disappearance time, lung wet rales Disappear time and hospital stay shorter than the control group, the difference was statistically significant (P <0.05). Conclusion Tanreqing combined azithromycin treatment of children with mycoplasma pneumonia can improve children’s efficacy, improve symptoms and shorten the treatment time, worthy of clinical promotion.